Gynecologic Cancer

SLN biopsy practicable for diagnosing cervical, endometrial cancers

Published in Cancer Weekly, August 3rd, 2004

Sentinel lymph node biopsy is feasible as a tool for diagnosing cervical and endometrial cancer, suggest physicians at the Hopital Europeen Georges Pompidou, Paris, France.

"The sentinel lymph node (SLN) biopsy has been proposed for the cancers of the uterus in order to optimize the diagnosis of lymphatic metastases and micrometastases in early stage tumors," said L. Lelievre and colleagues.

Lelievre's group enrolled 8 women with early invasive cervical cancer and 15 with endometrial cancer in a study of SLN biopsy for this purpose.

First each patient underwent a lymphoscintigraphy. Then "[i]ntraoperative SLN identification was...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-08-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry